ERYTECH Announces Opening of Operations at its New Princeton, NJ GMP Manufacturing Facility Post author:admERY Post published:June 24, 2019 Post category:Newsroom Inauguration event held last week to officially open 30,000 sq. ft GMP manufacturing facility constructed in Princeton, NJ to produce lead product candidate eryaspase in the United States. You Might Also Like ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics June 26, 2023 ERYTECH Provides Business Update and Financial Highlights for Q1 2017 May 18, 2017 ERYTECH wins the European Small and Mid-Cap Award in the Most Innovative Newcomer category December 10, 2015
ERYTECH wins the European Small and Mid-Cap Award in the Most Innovative Newcomer category December 10, 2015